Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 7/20 | 0.54 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | LIG1 | P18858 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24142017 | 0.83 | NPSR1 (0.55) | DAOPKMHPGDPOLBRAB9A | |
| SCHEMBL23682740 | 0.83 | LMNA (0.48) | DAOPKMHPGDRAB9AGAA | |
| SCHEMBL6735515 | 0.79 | PKM (0.69) | DAOPKMLIG1HPGDRAB9A | |
| SCHEMBL16471204 | 0.78 | DAO (0.48) | DAOPKMLIG1HPGDMEN1 | |
| SCHEMBL23745081 | 0.78 | POLB (0.44) | PKMHPGDMEN1POLBRAB9A | |
| SCHEMBL7892504 | 0.76 | DAO (0.47) | DAOPKMLIG1HPGDMEN1 | |
| SCHEMBL12368674 | 0.76 | DAO (0.47) | DAOPKMLIG1HPGDMEN1 | |
| SCHEMBL13155856 | 0.76 | DAO (0.47) | DAOPKMLIG1HPGDMEN1 | |
| SCHEMBL70493 | 0.75 | DAO (0.67) | DAOPKMLIG1HPGDMEN1 | |
| SCHEMBL27261592 | 0.75 | DAO (0.50) | DAOPKMLIG1HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107616976-B | A kind of pharmaceutical composition of Raltitrexed and preparation method thereof | 南京正大天晴制药有限公司 | 2019-06-21 | — | — | CN | claimed |
| CN-107616976-A | A kind of pharmaceutical composition of Raltitrexed and preparation method thereof | 南京正大天晴制药有限公司 | 2018-01-23 | — | — | CN | claimed |
| CN-108658931-B | Preparation method of raltitrexed key intermediate | 山东百诺医药股份有限公司 | 2020-08-04 | — | — | CN | disclosed |
| CN-107616976-B | A kind of pharmaceutical composition of Raltitrexed and preparation method thereof | 南京正大天晴制药有限公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-108658931-A | A kind of preparation method of Raltitrexed key intermediate | 山东百诺医药股份有限公司 | 2018-10-16 | — | — | CN | disclosed |
| CN-107616976-A | A kind of pharmaceutical composition of Raltitrexed and preparation method thereof | 南京正大天晴制药有限公司 | 2018-01-23 | — | — | CN | disclosed |